Advertisement

Canadian Journal of Public Health

, Volume 91, Supplement 1, pp S10–S16 | Cite as

Situation actuelle de l’hépatite C au Canada

  • Shimian Zou
  • Martin Tepper
  • Antonio Giulivi
Article
  • 1 Downloads

Current Status of Hepatitis C in Canada

Supplementary material

41997_2000_BF03405100_MOESM1_ESM.pdf (130 kb)
Supplementary material, approximately 133 KB.

Références

  1. 1.
    OMS (Organisation mondiale de la santé). Global surveillance and control of hepatitis C -report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Anvers, Belgique. J Viral Hepatitis 1999;6:35–47.CrossRefGoogle Scholar
  2. 2.
    Choo Q-L, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non A, non-B viral hepatitis genome. Science 1989;244:359–62.CrossRefGoogle Scholar
  3. 3.
    Altamirano M, Delaney A, Wong A, et coll. Identification of hepatitis C virus genotypes among hospitalized patients in British Columbia, Canada. J Infect Dis 1995;171(4):1034–38.CrossRefGoogle Scholar
  4. 4.
    Bernier L, Willems B, Delage G, Murphy DG. Identification of numerous hepatitis C virus genotypes in Montreal, Canada. J Clin Microbiol 1996;34(11):2815–18.PubMedPubMedCentralGoogle Scholar
  5. 5.
    Chaudhary RK, Tepper M, El Saadany S, Gully PR. Distribution of hepatitis C virus genotypes in Canada: Results from the LCDC sentinel health unit surveillance system. Can J Infect Dis 1999;10(1):53–56.CrossRefGoogle Scholar
  6. 6.
    Dienstag JL. Non-A, non-B hepatitis. I: Recognition, epidemiology, and clinical feature. Gastroenterology 1983;85:439–62.PubMedGoogle Scholar
  7. 7.
    Iwarson S, Norkrans G, Wejstal R. Hepatitis C: Natural history of a unique infection. Clin Infect Dis 1994;20:1361–70.CrossRefGoogle Scholar
  8. 8.
    Goodman ZD, Ishak KG. Histopathology of hepatitis C virus infection. Semin Liver Dis 1995;15:70–81.CrossRefGoogle Scholar
  9. 9.
    Sharara AI, Hunt CM, Hamilton JD. Hepatitis C. Ann Intern Med 1996;125:658–68.CrossRefGoogle Scholar
  10. 10.
    Gully PR, Tepper ML. Hepatitis C. CMAJ 1997;156(10):1427–30.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26(3 Suppl 1):62S–65S.CrossRefGoogle Scholar
  12. 12.
    Alter MJ, Mast EE, Moyer LA, Margolis HS. Hepatitis C. Infect Dis Clin North Am 1998;12(1):13–26.CrossRefGoogle Scholar
  13. 13.
    ACEF (Association canadienne pour l’étude du foie). Management of Viral Hepatitis. Association canadienne pour l’étude du foie, 1999.Google Scholar
  14. 14.
    Remis R, Hogg R, Krahn MD, et coll. Estimation du nombre de transfusés infectés par le virus de l’hépatite C au Canada, 1960–1985 et 1990–1992. Rapport présenté à Santé Canada, juin 1998.Google Scholar
  15. 15.
    Strathdee SA, Patrick DM, Currie SL, et coll. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS 1997;11(8):F59–F65.CrossRefGoogle Scholar
  16. 16.
    Ford PM, White C, Kaufmann H, et coll. Voluntary anonymous linked study of the prevalence of HIV infection and hepatitis C among inmates in a Canadian federal penitentiary for women. CMAJ 1995;153(11):1605–9.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Prefontaine RG, Chaudhary RK. Seroepidemiologic study of hepatitis B and C viruses in federal correctional institutions in British Columbia. Can Dis Wkly Rep 1990;16(52):265–66.PubMedGoogle Scholar
  18. 18.
    Slinger R, Saadany S, Tepper M, et coll. Seroprevalence of and risk factors for hepatitis C and hepatitis B in street youth in Ottawa, Canada. Paediatr Child Health 1999;4(Suppl B):48B.Google Scholar
  19. 19.
    Sandhu J, Preiksaitis JK, Campbell PM, et coll. Hepatitis C prevalence and risk factors in the northern Alberta dialysis population. Am J Epidemiol 1999;150(1):58–66.CrossRefGoogle Scholar
  20. 20.
    Scully LJ, Mitchell S, Gill P. Clinical and epi-demiological characteristics of hepatitis C in a gastroenterology/hepatology practice in Ottawa. CMAJ 1993;148:1173–77.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Stratton E, Sweet L, Latorraca-Walsh A, Gully PR. Hepatitis C in Prince Edward Island: A descriptive review of reported cases, 1990–1995. Can J Public Health 1997;88(2):91–94.PubMedGoogle Scholar
  22. 22.
    Seeff LB, Miller RN, Rabkin CS, et coll. 45-year follow-up of hepatitis C virus infection in healthy young adults. Ann Intern Med 2000;132:105–11.CrossRefGoogle Scholar
  23. 23.
    LLCM. Prévention de l’hépatite C: un consensus en santé publique. Relevé des maladies transmis-sibles au Canada 1999;25S2:1–25.Google Scholar
  24. 24.
    LLCM. Un protocole intégré pour la prise en charge des travailleurs de la santé exposés à des pathogènes transmissibles par le sang. Relevé des maladies transmissibles au Canada 1997;23S2:1–16.Google Scholar
  25. 25.
    LLCM. Compte rendu de la Conférence de concertation sur les professionnels de la santé infectés: risque de transmission des pathogènes à diffusion hématogène. Relevé des maladies trans-missibles au Canada 1998;24S4:1–28.Google Scholar
  26. 26.
    LLCM. Pratiques de prévention des infections dans les services personnels: tatouage, perçage des oreilles, perçage corporel et électrolyse. Relevé des maladies transmissibles au Canada 1999;25S3:1–82.Google Scholar

Copyright information

© The Canadian Public Health Association 2000

Authors and Affiliations

  • Shimian Zou
    • 1
  • Martin Tepper
    • 1
  • Antonio Giulivi
    • 1
  1. 1.Division des agents pathogènes à diffusion hématogène, Bureau des maladies infectieusesLaboratoire de lutte contre la maladieOttawaCanada

Personalised recommendations